EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss

Autor: Yu, T, Dulai, PS, Griffith, J, Sharma, D, Loftus, EV

Publikováno v: In Value in Health June 2024 27(6) Supplement:S131-S132

Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis.

Autor: Dulai PS, Rothstein RI

Publikováno v: Journal of Clinical Gastroenterology; 2012 May/Jun, Vol. 46 Issue 5, p367-374, 8p

Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis.

Autor: Narula N; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada., Hamam H; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada., Liu J; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada., Wong ECL; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada., Marshall JK; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada., Jairath V; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada., Hanauer SB; Division of Gastroenterology, Northwestern University, Chicago, IL, USA., Reinisch W; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria., Dulai PS; Division of Gastroenterology, Northwestern University, Chicago, IL, USA.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Nov 04; Vol. 18 (11), pp. 1863-1869.

Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.

Autor: Dulai PS; Division of Gastroenterology and Hepatology, Northwestern University, Chicago, Illinois, USA., Bonner LB; Department of Preventive Medicine, Division of Biostatistics, Northwestern University, Chicago, Illinois, USA.; Northwestern University Data Analysis and Coordinating Center (NUDACC), Chicago, Illinois, USA., Sadler C; Division of Hyperbaric Medicine, Department of Emergency Medicine, University of California San Diego, La Jolla, California, USA., Raffals LE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Kochhar G; Division of Gastroenterology and Hepatology, Alleghany Health, Pittsburgh, Pennsylvania, USA., Lindholm P; Division of Hyperbaric Medicine, Department of Emergency Medicine, University of California San Diego, La Jolla, California, USA., Buckey JC Jr; Hyperbaric Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA., Toups GN; Hyperbaric Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rosas L; Division of Gastroenterology and Hepatology, Northwestern University, Chicago, Illinois, USA., Narula N; Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada., Jairath V; Division of Gastroenterology, Schulich School of Medicine, Western University, London, Ontario, Canada.; Lawson Health Research Institute, Western University, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada., Honap S; School of Immunology and Microbial Sciences, King's College London, UK.; INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France., Peyrin-Biroulet L; INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hanauer SB; Division of Gastroenterology and Hepatology, Northwestern University, Chicago, Illinois, USA., Scholtens DM; Department of Preventive Medicine, Division of Biostatistics, Northwestern University, Chicago, Illinois, USA.; Northwestern University Data Analysis and Coordinating Center (NUDACC), Chicago, Illinois, USA., Siegel CA; Division of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Acute severe ulcerative colitis trials: the past, the present and the future.

Autor: Honap S; King's College London, School of Immunology & Microbial Sciences, London, UK.; INFINY Institute, Nancy University Hospital Center, Vandœuvre-lès-Nancy, France., Jairath V; Departments of Gastroenterology and Medicine, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada.; Departments of Epidemiology and Biostatistics, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dulai PS; Division of Gastroenterology, Northwestern University, Evanston, Illinois, USA., Danese S; Department of Gastroenterology and Endoscopy, San Raffaele Hospital, Milan, Italy., Peyrin-Biroulet L; INFINY Institute, Nancy University Hospital Center, Vandœuvre-lès-Nancy, France peyrinbiroulet@gmail.com.; Inserm NGERE U1256, University of Lorraine, Nancy, Vandœuvre-lès-Nancy, France.

Publikováno v: Gut [Gut] 2024 Sep 09; Vol. 73 (10), pp. 1763-1773. Date of Electronic Publication: 2024 Sep 09.